Aatru Medical, LLC is a privately held medical device company specializing in developing new technologies designed to improve the healthcare experience for clinicians, patients, families, and caregivers.
The name of our company, Aatru, means healing.We are committed to providing innovative wound care products that are clinically effective, safe, and affordable.
Aatru has developed and commercialized NPSIMS, the first true innovation in NPWT in over 10 years, with a goal of improving the patient and clinician experience and increasing affordable access to NPWT for surgical incision management.
Aatru is the parent company of Exothermix, the inventor and supplier of the unique oxygen scavenger used in the mode of action for NPSIMS.
The primary purpose of NPWT in surgical incision management is to reduce surgical site complications, such as infection and dehiscence.
Incision management with NPWT has a number of additional benefits in clinical practice including:
Surgical incision management may be appropriate for patients with co-morbidities that can affect wound healing, including but not limited to:
NPWT has been used on closed surgical incisions following a variety of different types of surgery, including:
To establish in-vivo validation of the Aatru negative pressure wound therapy O2 scavenger mode of action, an animal study was conducted at University of Miami, Miller School of Medicine, Department of Dermatology and Cutaneous Surgery, Wound Healing Research Laboratory. Testing for:
Usability and Human Factors validation tests were conducted to assess the design of the Aatru NPSIMS with respect to user input to the Design Specification and Requirements.
The Usability Test is intended to be a summative evaluation of qualitative investigations that are reported from observations of User interactions with the device’s user interfaces and the description of their experiences.
Aatru Medical Announces Clinical Study and Interim Analysis of their NPSIMS Negative Pressure Surgical Incision Management System
For Immediate Release: October 20, 2021
Aatru Medical Announces FDA Clearance and Commercial Launch of the NPSIMS – Negative Pressure Surgical Incision Management System
For Immediate Release: August 24, 2021
Aatru Medical Abstract Accepted for Presentation in Two Leading 2020 Wound Healing Conferences
For Immediate Release: August 18, 2020
Aatru Medical, LLC submits NPSIMS product to FDA for Class II Clearance and completes Series C funding
For Immediate Release: July 14, 2020
An international group of surgical care experts discuss the challenges involved in closed surgical incision management and the interventions such as NPWT that can be used to reduce the risk of surgical site complications.
The World Health Organization has created a comprehensive set of global guidelines for the prevention of surgical site infection.
The Journal of Tissue Viability has published a paper that discusses how negative pressure wound therapy is thought to improve wound healing by altering capillary perfusion, entitled “Pressure distribution and flow characteristics during negative pressure wound therapy.”
“Closed Incision Negative Pressure Therapy Is Associated with Reduced Surgical Site Infections in Gynecologic Oncology Patients Undergoing Laparotomy” Chambers, et al.
Aatru Medical, LLC
1301 East 9th Street
Cleveland, OH 44114